Press Releases

Date	Title	Company
05-Jan-2023	Medical Device Outsourcing Market is geared to grow at a CAGR of 11.5% from 2023 to 2032 \| insightSLICE	insightSLICE
05-Jan-2023	iOnctura provides development update on first-in-class semi-allosteric PI3Kδ inhibitor program	iOnctura
05-Jan-2023	Coagulation Analyzers Market to achieve CAGR of 7.5% by 2032, owing to increasing the prevalence of heart diseases \| insightSLICE	insightSLICE
05-Jan-2023	Cell and Tissue Preservation Market expanding growth at a CAGR of 11% from 2023 to 2032, owing to rising prevalence of injuries \| insightSLICE	insightSLICE
05-Jan-2023	Blood Clot Retrieval Devices Market exhibiting CAGR of 14% by 2032, owing to growing prevalence of stroke \| insightSLICE	insightSLICE
05-Jan-2023	Asparaginase Market is anticipated to expand at a CAGR of 16.1% By 2032 \| Exclusive Report by insightSLICE	insightSLICE
05-Jan-2023	BioVersys Extends its Series C Round to CHF 32.6 Million with Investment from the AMR Action Fund	B3C newswire
05-Jan-2023	MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability	MorphoSys AG
05-Jan-2023	Ad hoc: MorphoSys AG Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability	MorphoSys AG
05-Jan-2023	Orion and Amneal enter strategic partnership – Orion receives exclusive licence to commercialise Amneal’s generic products in Europe, Australia and New Zealand	Orion Corporation
05-Jan-2023	Sosei Heptares Notes its Partner Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use Disorders	Sosei Heptares
05-Jan-2023	Transgene Announces Financial Calendar for 2023	Transgene
05-Jan-2023	Passive or active delivery devices in diabetes administration?	MindMetre Research
05-Jan-2023	Biophytis announces its participation in two major investor conferences in January, in the United States and in France: the JP Morgan Healthcare Conference and the Invest Securities Biomed	Biophytis
05-Jan-2023	Abivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action	ABIVAX
05-Jan-2023	STEMart Introduces API Impurity Identification Services for Medical Devices	STEMart
05-Jan-2023	CD BioSciences Introduces Label-Free Live Cell Imaging Services for Bio-Research	CD BioSciences
05-Jan-2023	CD BioSciences Introduces Various Solutions for Autophagic Cell Death Studies	CD BioSciences
04-Jan-2023	SYNLAB AG: Portuguese competition authority investigating the local laboratory diagnostics market – SYNLAB’s operations in Portugal included in such investigation	SYNLAB AG
04-Jan-2023	SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB	SYNLAB AG